The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C05 | Vasoprotectives | |
| 3 | C05B | Antivaricose therapy | |
| 4 | C05BB | Sclerosing agents for local injection | |
| 5 | C05BB04 | Sodium tetradecyl sulfate |
| Active Ingredient | Description | |
|---|---|---|
| Sodium tetradecyl sulfate |
Sodium tetradecyl sulfate is a sclerosing agent. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| FIBROVEIN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
